Escrito por estudiantes que aprobaron Inmediatamente disponible después del pago Leer en línea o como PDF ¿Documento equivocado? Cámbialo gratis 4,6 TrustPilot
logo-home
Examen

NR 546 Final Exam: PMHNP Psychopharmacology Study Guide

Puntuación
-
Vendido
-
Páginas
120
Grado
A+
Subido en
26-06-2026
Escrito en
2025/2026

Pass NR 546 with Q&As on antidepressants, mood stabilizers, antipsychotics, ADHD meds, opioid use disorder, Alzheimer's, and sleep disorders.

Institución
Grado

Vista previa del contenido

NR 546 Final Exam Questions and Answers Latest Update
2024/2025
1. Pharmacologic Treatment of Bipolar Disorder

Lithium

Anticonvulsants

Second generation antipsychotics

2. Unipolar depression

major depressive disorder (MDD)

one of the most common mental disorders

-Approximately 7.1% of adults in the U.S. had episode in last year, prevalence highest

(13.1%) among individuals aged 18-25



S/S

-depressed mood

-loss of interest or pleasure in daily activities

-irritability

-withdrawal

-problems with sleep, eating, energy, concentration, or self-worth

-severe depression: may experience thoughts of suicide or psychotic symptoms.

3. Bipolar disorder (BD)

Chronic condition characterized by extreme fluctuations in mood, energy, and ability to

function

-Moods may be manic, hypomanic, or depressed and may include mixed mood or

, psychotic features

-many have only experienced only one manic episode in their lifetime

-Mood fluctuations may be separated by periods of high stability or may cycle rapidly

-diagnosed when a client has one or more episodes of mania or hypomania with a

history of one or more major depressive episodes

-high risk for suicide

4. mania

characterized by a persistently elevated, expansive, or irritable mood. Related

symptoms may include inflated self-esteem, increased goal-directed activity or energy,

including grandiosity, decreased need for sleep, excessive talkativeness, racing

thoughts, flight of ideas (FOI), distractibility, psychomotor agitation, and a propensity to

be involved in high-risk activities. Mania leads to significant functional impairment and

may include psychotic features or necessitate hospitalization

5. Bipolar Type I:

requires at least one episode of mania for at least one week (or any duration if

hospitalization due to symptoms is required)

6. Bipolar Type II:

diagnosis requires a current or past hypomanic episode and a current or past major

depressive episode. Symptoms last for at least 4 days but fewer than seven.

-Hypomanic symptoms are not of sufficient duration or severity to cause significant

functional impairment, psychosis, or hospitalization.

-Anger and irritability are common.

,-Clients often enjoy the elevation of mood and are reluctant to report these symptoms,

making bipolar more difficult to diagnose if the client presents in the depression phase.

7. Cyclothymia:

involves the chronic presentation of hypomanic and depressive symptoms that do not

meet the diagnostic criteria for a major depressive or manic/hypomanic episode.

8. If bipolar depression is mistaken for MDD:

antidepressant therapy may precipitate a manic episode or induce rapid-cycling bipolar

depression

-may contribute to the increased incidence of death by suicide in children and adults

younger than 25

9. Antidepressants are used cautiously in clients with bipolar disorder and

never as ________________.

monotherapy

-Antidepressants should be combined with a mood stabilizer to prevent the onset of a

hypomanic or manic episode

10. DA, NE Dysfunction causes what mood related symptoms

Decreased positive affect:

depressed mood

loss of joy

lack of interest

loss of energy

decreased alertness

, decreased self-confidence

appetite changes

11. 5HT, NE Dysfunction causes what mood related symptoms

Increased negative affect:

depressed mood

guilt

fear/anxiety

hostility

irritability

loneliness

appetite changes

12. monoamine hypothesis of depression

-depression occurs as a result of a deficiency of one or all three monoamine

transmitters

• serotonin, norepinephrine, and dopamine

-while mania may result from an excess

13. Medication Management for Depression, First-Line Treatment:

• Selective Serotonin Reuptake Inhibitors (SSRIs)

• Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

• Norepinephrine Dopamine Reuptake Inhibitors (NDRI)

• Serotonin Antagonist and Reuptake Inhibitors (SARIs)

14. SSRI's

Escuela, estudio y materia

Institución
Grado

Información del documento

Subido en
26 de junio de 2026
Número de páginas
120
Escrito en
2025/2026
Tipo
Examen
Contiene
Preguntas y respuestas

Temas

$22.49
Accede al documento completo:

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Conoce al vendedor
Seller avatar
lucastravis

Conoce al vendedor

Seller avatar
lucastravis Alabama A&M University
Seguir Necesitas iniciar sesión para seguir a otros usuarios o asignaturas
Vendido
-
Miembro desde
2 semanas
Número de seguidores
0
Documentos
3
Última venta
-

0.0

0 reseñas

5
0
4
0
3
0
2
0
1
0

Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes